Chargement en cours...
An update on the clinical evidence that supports biosimilar approvals in Europe
AIM: Sponsors and regulators have more than 10 years of experience with the development of biosimilars in Europe. However, the regulatory pathway is still evolving. The present article provides an update on biosimilar development in practice by reviewing the clinical development programmes of recent...
Enregistré dans:
| Publié dans: | Br J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6005614/ https://ncbi.nlm.nih.gov/pubmed/29575017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13586 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|